Restore Medical, Inc.

Medtronic Xomed, Inc.

Enteromedics Inc.

Medtronix Xomed, Inc.

John P Sopp

Timothy R Conrad

Brian J Erickson

Anja Metzger

Mark B Knudson

Susan L Critzer

Katherine S Tweden

Kurt D Krueger

John R Frigstad

Larry A Walter

Anja K Metzger

A pharyngeal airway having a pharyngeal wall of a patient at least partially surrounding and defining the airway is treated by selecting an implant dimensioned so as to be implanted at or beneath a mucosal layer of the pharyngeal wall and extending transverse to said wall. The implant has mechanical characteristics for the implant, at least in combination with a fibrotic tissue response induced by the implant, to stiffen said pharyngeal wall to resist radial collapse. The implant is implanted into the pharyngeal wall transverse to a longitudinal axis of the airway.

Stiffening pharyngeal wall treatment

Treatment for sleep apnea or snoring

An airway condition of a patient's is treated by selecting an implant sized to be implanted within a tongue of the patient. The implant has a tissue-engaging member sized to be implanted within the tongue near a base of the tongue to oppose relative movement between the tissue-engaging member and surrounding tissue of the tongue. The implant further has an elongated tether member with a first end secured to the tissue-engaging member. The implant is placed within the tongue with the tissue-engaging member implanted within tissue of the tongue near the base and with the tether member extending from the first end to a second end near a jaw bone of the patient. The second end of the tether is secured to the jaw bone.

Tongue implant

An airway condition of a patient is treated by selecting an implant sized to be implanted within a soft palate of the patient. The implant has a tissue-engaging member sized to be implanted within the soft palate near a trailing end of the soft palate to oppose relative movement between the tissue-engaging member and surrounding tissue of the soft palate. The implant further has an elongated tether member with a first end secured to the tissue-engaging member. The implant is placed within the soft palate with the tissue-engaging member implanted within tissue of the soft palate near the trailing end and with the tether member extending from the first end to a second end near a hard palate of the patient. The second end of the tether is secured to the hard palate.

Soft palate implant

Methods and apparatuses are disclosed for treating a condition of a patient's airway. The condition is attributed at least in part to a spacing of tissue from opposing surfaces in the airway. In various embodiments, the base of the tongue including geometry and position of the tongue is altered.

Airway implant

A method and apparatus are disclosed for treating a condition of a patient's airway. The condition is attributed at least in part to a spacing of tissue from opposing surfaces in the airway. In one embodiment, the method and apparatus include placing a tissue contractor within the tissue. The contractor includes a static end and a tissue in-growth engaging end. The static end is secured to a bony structure adjacent to tissue to be contracted. The tissue in-growth engaging end is secured to the tissue and spaced from the bony structure. A spacing between the tissue engaging end and a bony end is contracted in order to place the tissue under tension.

The method of the invention includes accessing a juncture of an esophagus and a stomach of the patient on a distal side of a diaphragm. The esophagus and a fundus of the stomach intersect at a cardiac notch located at an original cardiac notch position. A reducing element is placed at the junction with the reducing element selected to reposition the cardiac notch to a position more distal to a lower esophageal sphincter of the patient.

Gastro-esophageal reflux disease (GERD) treatment method and apparatus

Implant delivery tool

An intraluminal stent comprises a reticulated tube having an un-deployed diameter and expandable to an enlarged diameter. When the tube is at the un-deployed diameter, the tube has cell-defining portions with opposing surfaces defining an open cell bounded by the cell-defining portions.

Growing community of inventors

Forest Lake, MN, United States of America

John P Sopp